Document Detail

Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma.
MedLine Citation:
PMID:  17981018     Owner:  NLM     Status:  MEDLINE    
AIMS: To investigate the relationships between integrin alphanubeta6 expression and the clinical-pathological features of gastric carcinoma and whether integrin alphanubeta6 can act as a prognostic indicator in gastric carcinoma. MATERIALS AND METHODS: We generated the microarray of 300 human gastric carcinoma specimens, and used the method of immunohistochemistry to investigate the expression of alphanubeta6 in them and the relationships between the expression of alphanubeta6 and the clinical-pathological features of the tumours. Meanwhile, we retrospectively analysed the relationship between alphanubeta6 expression and the survival times of the patients. RESULTS: The expression of alphanubeta6 was detected in 36.7% of gastric carcinomas, and the expression was associated with Lauren type, differentiation, N stage and TNM stage of the tumours (the P values were 0.004, 0.035, 0.024 and 0.001, respectively). The Kaplan-Meier plot showed that patients who were alphanubeta6 negative had much longer survival times than those who were alphanubeta6 positive (P<0.0001). The survival estimates showed a striking difference in median survival between the negative and positive alphanubeta6 expression patients, especially in early stage tumours. Univariate analysis indicated that significant factors for prognosis included alphanubeta6 expression, differentiation, TNM stage, T stage, N stage, M stage and R classification (R0: potentially curative resection; R1: had residual microscopic disease after resection; R2: had residual macroscopic disease after resection), whereas in multivariate analysis using the Cox regression model, only alphanubeta6 expression, M stage, TNM stage and R classification retained significance for prognosis. CONCLUSIONS: Positive alphanubeta6 expression in gastric carcinoma is linked to significantly reduced survival times and, even more important, is that its value as a prognostic marker is significant for early stage tumours.
Z-Y Zhang; K-S Xu; J-S Wang; G-Y Yang; W Wang; J-Y Wang; W-B Niu; E-Y Liu; Y-T Mi; J Niu
Related Documents :
17413988 - Identification of potential prognostic markers for vulvar cancer using immunohistochemi...
19362968 - Prognostic relevance of 6q deletion in waldenström's macroglobulinemia: a multicenter s...
16445668 - Expression and amplification of her-2/neu oncogene in uterine carcinosarcomas: a marker...
16786118 - Does the degree of intratumoural microvessel density and vegf expression have prognosti...
7902398 - Heterogeneity in the development of apoptosis in irradiated murine tumours of different...
18496188 - Diagnosis and management of intracranial malignant peripheral nerve sheath tumors.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-11-05
Journal Detail:
Title:  Clinical oncology (Royal College of Radiologists (Great Britain))     Volume:  20     ISSN:  0936-6555     ISO Abbreviation:  Clin Oncol (R Coll Radiol)     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-01-21     Completed Date:  2008-06-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002902     Medline TA:  Clin Oncol (R Coll Radiol)     Country:  England    
Other Details:
Languages:  eng     Pagination:  61-6     Citation Subset:  IM    
Department of General Surgery of QiLu Hospital Affiliated Shandong University, Jinan 250012, Shandong, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, Neoplasm / analysis*
Carcinoma / chemistry,  mortality,  pathology*
Disease-Free Survival
Integrins / analysis*
Middle Aged
Stomach Neoplasms / chemistry,  mortality,  pathology*
Survival Analysis
Tumor Markers, Biological / analysis*
Reg. No./Substance:
0/Antigens, Neoplasm; 0/Integrins; 0/Tumor Markers, Biological; 0/integrin alphavbeta6

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Overnight features of transcutaneous carbon dioxide measurement as predictors of metabolic status.
Next Document:  Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with ac...